Christopher Wallenhorst

8PUBLICATIONS
11CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Behavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 01, 2024
Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK Study.

Alexander T Cohen, Christopher Wallenhorst, Marcella Rivera

|Aug 01, 2023
A Novel Risk Prediction Score for Clinically Significant Bleeding in Patients Anticoagulated for Venous Thromboembolism with Active Cancer.

Alexander T Cohen, Christopher Wallenhorst, Satarupa Choudhuri

|Aug 11, 2021
Refined atrial fibrillation screening and cost-effectiveness in the German population.

Renate B Schnabel, Christopher Wallenhorst, Daniel Engler

Pageof 2